Last week, controversy over the claims over the prowess of eye drops prescribed for presbyopia (progressive loss of the near focusing ability of the eye due to ageing), led to the Central Drugs ...

ENTOD Pharmaceuticals has recently launched PresVu eye drops, which have been approved by the Drug Controller General of India (DCGI). Marketed as a potential breakthrough for presbyopia — a ...

PresVu eye drops, developed by Entod Pharmaceuticals, were launched with considerable media attention earlier this month as a novel solution for presbyopia. Presbyopia is a condition where ...

A Place In The Sun presenter Jean Johannsson has been diagnosed with presbyopia - the gradual loss of your eyes' ability to focus on nearby objects. After being in denial about her declining ...

Presbyopia, the gradual loss of ability to focus on near objects, typically becomes noticeable in the early to mid-40s. This progressive and ubiquitous condition leads to the widespread use of ...

Image Credit: Getty Images Courtney Dryer, OD, identifies obstacles to successful contact lens wear in patients with presbyopia and suggests strategies clinicians can use to determine which patients ...

These drops have been specially developed for people who have presbyopia, an eye-related condition that affects those above the age of 40, according to Network 18. Starting in the first week of ...

Presbyopia is an age-related condition in which the eyes gradually lose the ability to focus on nearby objects. People usually start to develop presbyopia at around the age of 40. According to doctors ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

According to industry estimates, 1.09-1.8 billion individuals globally are estimated to be affected by presbyopia. The ...

LENZ Therapeutics (formerly Presbyopia Therapies) is working on eyedrops containing aceclidine – thought to act like pilocarpine as a miotic agent, reducing eye pressure – showed improvements ...